Top 10 Deals of 2023: Imaware Acquires Binx Health’s STI Testing Business
This week we assess the acquisition of Binx Health, an at-home STI testing company and consider similar pioneers in the sexual health space.
Top 10 Deals of 2023: Menopause Drug Intrarosa Acquired by Cosette Pharmaceuticals
This week we discuss what the acquisition of Intrarosa means for the industry and consider similar pioneers in the women’s health space.
Top 10 Deals of 2023: Evernow Raises a $28.5M Series A
This week we acknowledge Evernow’s fundraising success and highlight the positive impact they are making in the field of women’s health.
Top 10 Deals of 2023: Breast Cancer Therapeutic Company is Acquired by Gilead
This week we discuss what the acquisition of XinThera means for the industry and consider similar pioneers in the women’s health space.
Top 10 Deals of 2023: Kindbody Announces $100 Million Raise
This week we reflect on the remarkable trajectory of Kindbody’s growth, applauding their substantial fundraising achievements, underscoring the positivity it brings to the women’s health sector.
Top 10 Deals of 2023: Pregnancy Care Company, Nuvo Group, merges with LAMF Global Ventures
This week we discuss what the merger of Nuvo Group and LAMF Global Ventures means for the industry and consider similar pioneers in the women’s health space.
Top 10 Deals of 2023: Thorne HealthTech Acquired for $680M by L. Catterton
This week we discuss what the acquisition of Thorne HealthTech means for the industry and consider similar pioneers in the women’s health space.
Evvy, an Amboy Street Portfolio Company, Raises a $14M SeriesA
Amboy Street Ventures announces its latest investment in Evvy, a company committed to restoring equity in healthcare by leveraging overlooked female biomarkers, starting with the vaginal microbiome.
Industry Insights: What CPG Conglomerates Look for in Acquisition Targets
This week, Ute M. Arndt, reveals what CPG conglomerates find valuable when considering an acquisition of a start-up.